Korsuva ® (Difelikefalin)
AI Summary
UnitedHealthcare has updated their medical benefit drug policy for Korsuva (Difelikefalin), which is used to treat chronic kidney disease-associated pruritus in adult hemodialysis patients. This policy update will take effect July 1, 2026 and may impact coverage criteria, prior authorization requirements, or billing procedures for this specialty medication.
Action Required
By June 30, 2026: Billing teams should review the updated Korsuva (Difelikefalin) medical benefit drug policy in the June 2026 Medical Policy Update Bulletin to understand any changes to coverage criteria, prior authorization requirements, or billing procedures. Nephrology practices and dialysis centers should update their workflows accordingly before the July 1, 2026 effective date.
Plan Types
Commercial
Specialties
nephrology